SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shukra Pharmaceuticals informs about disclosure

05 Apr 2024 Evaluate
Shukra Pharmaceuticals has informed that the Shareholders through postal ballot have approved the alteration to clause 5 of the Memorandum of Association (MOA) of the company. And article clause no,3B(ii)(d) of Article of Association(AoA) of the company Accordingly, the MOA of the Company has been altered as follows: The Authorized Share capital of the company is Rs 44,00,00,000 (Rupees Forty-four crore only) consisting of 4,40,0d,000 (Four Crore Forty Lakh) Equity Shares of Rs 10 each.’

The above information is a part of company’s filings submitted to BSE.

Shukra Pharma Share Price

34.90 -1.16 (-3.22%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×